OBJECTIVE: The aim of the study was the longitudinal analysis of the influence of social and clinical factors on the mid-term costs of schizophrenia treatment. METHOD: Treatment costs as well as clinical and social characteristics of 307 patients with the ICD-10 diagnosis of schizophrenia were assessed at five follow-ups over 2.5 years. Between and within effects of clinical and social characteristics on treatment costs were estimated by error component regression models. RESULTS: Effects caused by differences between individuals were found for age, partnership, in-patient history, objective and subjective role functioning, life-events and psychotic relapse. Effects of idiosyncratic transitory changes of social and clinical characteristics were found for symptoms, psychotic relapse, and for social role-functioning. CONCLUSION: Treatment costs can be reduced to a limited extent not only by the prevention of psychotic symptoms and relapse but also by the improvement of role-functioning capacities.
OBJECTIVE: The aim of the study was the longitudinal analysis of the influence of social and clinical factors on the mid-term costs of schizophrenia treatment. METHOD: Treatment costs as well as clinical and social characteristics of 307 patients with the ICD-10 diagnosis of schizophrenia were assessed at five follow-ups over 2.5 years. Between and within effects of clinical and social characteristics on treatment costs were estimated by error component regression models. RESULTS: Effects caused by differences between individuals were found for age, partnership, in-patient history, objective and subjective role functioning, life-events and psychotic relapse. Effects of idiosyncratic transitory changes of social and clinical characteristics were found for symptoms, psychotic relapse, and for social role-functioning. CONCLUSION: Treatment costs can be reduced to a limited extent not only by the prevention of psychotic symptoms and relapse but also by the improvement of role-functioning capacities.
Authors: Silke Wiegand-Grefe; Bonnie Filter; Mareike Busmann; Reinhold Kilian; Klaus-Thomas Kronmüller; Martin Lambert; Christine Norra; Kai von Klitzing; Kurt Albermann; Sibylle Maria Winter; Anne Daubmann; Karl Wegscheider; Angela Plass-Christl Journal: Front Psychiatry Date: 2021-01-20 Impact factor: 4.157
Authors: Bernd Puschner; Sabine Steffen; Wolfgang Gaebel; Harald Freyberger; Helmfried E Klein; Tilman Steinert; Rainer Muche; Thomas Becker Journal: BMC Health Serv Res Date: 2008-07-21 Impact factor: 2.655
Authors: Anna Alonso-Solís; Susana Ochoa; Eva Grasa; Katya Rubinstein; Asaf Caspi; Kinga Farkas; Zsolt Unoka; Judith Usall; Elena Huerta-Ramos; Matti Isohanni; Jussi Seppälä; Elisenda Reixach; Jesús Berdún; Iluminada Corripio; M-Resist Group Journal: Int J Environ Res Public Health Date: 2020-10-16 Impact factor: 3.390